Viridian Therapeutics, Inc. — Form D
Viridian Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-29. The offering totals $27.0M, of which $27.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-29
- Form: D
- Accession: 0001811466-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $27.0M
- Amount sold: $27.0M
- Investors: 9
- Date of first sale: 2020-09-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-376545
Issuer
- Name: Viridian Therapeutics, Inc.
- CIK: 0001811466
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 203 CRESCENT STREET, WALTHAM, MA, 02453
- Phone: 919-949-8552
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Peter Harwin | Director | West Conshohocken, PA |
| Tomas Kiselak | Director | West Conshohocken, PA |
| Jonathan Violin | Director | Waltham, MA |
| Jonathan Violin | Executive Officer | Waltham, MA |
Other filings by this issuer (1)
More